Home/References
PUBLICATIONS
References and publications
All links on this page direct to article abstracts. Full versions are available at the Interventional Psychiatry Centre.
Interventional psychiatry in Switzerland
Swiss Society of Interventional Psychiatry (SSPI)
Other specialists: Dr Fady Rachid (Geneva, TMS) · Dr Michael Fischer (Zürich, TMS and other techniques)
DEXDexmedetomidine, depression and anxiety
▼
Al-Mahrouqi T et al. Clin Pract Epidemiol Ment Health. 2023;19:e174501792307240
Liu Y et al. J Affect Disord. 2023;347:437-444
Breault MS et al. Annu Rev Neurosci. 2025;48(1):103-124
Bosch OG et al. Pharmacopsychiatry. 2022;56(2):44-50
N₂ONitrous oxide for depression
▼
Salamé A, Bulteau S, Robert G, et al. EClinicalMedicine. 2026;94:103860
Williams E, Cowen PJ. Biol Psychiatry Glob Open Sci. 2025;5(5):100551
Liu H et al. Acta Psychiatr Scand. 2022;146(2):126-138
Kalmoe MC et al. J Neurol Sci. 2020;412:116778
de Leon VC et al. J Clin Psychiatry. 2023;84(5)
Qiu Y et al. Psychopharmacology (Berl). 2023;240(10):2033-2043
Gillman MA. Curr Drug Res Rev. 2019;11(1):12-20
Nagele P et al. J Clin Psychopharmacol. 2018;38(2):144-148
Quach DF et al. J Neurol Sci. 2021;434:120092
Bouhassira D et al. Pain. 2021;162(4):1104-1115
Nagele P et al. Sci Transl Med. 2021;13(597)
TMSGeneral information on TMS
▼
TMS-Thérapie
TMSEfficiency and safety of TMS
▼
Lefaucheur JP et al. Clin Neurophysiol. 2014;125(11):2150-2206
Rossi S et al. Clin Neurophysiol. 2020;132(1):269-306
Rossi S et al. Clin Neurophysiol. 2020;132(1):269-306
TMSTMS efficiency for depression
▼
Wang VX-Y, Mehta DD, Downar J, et al. Brain Stimul. 2026;19:103129
Perera T et al. Brain Stimul. 2016;9(3):336-346
O’Reardon JP et al. Biol Psychiatry. 2007;62(11):1208-16
Li H et al. J Affect Disord. 2021;287:115-124
Sabesan P et al. World J Psychiatry. 2015;5(2):170-81
Baeken C et al. J Affect Disord. 2013;151(2):625-631
Trapp NT et al. Clin Neurophysiol. 2025;170:206-233
Brini S et al. Clin Psychol Rev. 2023;100:102236
Marwaha S et al. Lancet. 2023;401(10371):141-153
Blumberger DM et al. JAMA Psychiatry. 2022;79(11):1065-1073
Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Lancet. 2018;391(10131):1683-1692
McClintock SM, Reti IM, Carpenter LL, et al. J Clin Psychiatry. 2018;79(1):16cs10905
Lefaucheur JP, Colzi C, Hollander E, et al. Neurosci Biobehav Rev. 2025;169:106018
Brunoni AR, Chaimani A, Moffa AH, et al. JAMA Psychiatry. 2017;74(2):143-152
Conroy SK, Holtzheimer PE. Am J Psychiatry. 2021;178(12):1082-1088
Vida RG, Sághy E, Bella R, et al. BMC Psychiatry. 2023;23(1):545
Dalhuisen I, van Bronswijk S, Bors J, et al. Neurosci Biobehav Rev. 2022;141:104848
Li J, Cui L, Li H, et al. Front Psychiatry. 2022;13:1038312
TMSTMS efficiency for other indications
▼
Terraneo A et al. Eur Neuropsychopharmacol. 2015;26(1):37-44
Galhardoni R et al. Arch Phys Med Rehabil. 2014;96(4 Suppl):S156-72
Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia.
Mhalla A et al. Pain. 2011;152(7):1478-1485
Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder.
Karsen EF et al. Brain Stimul. 2013;7(2):151-7
Fitzsimmons SMDD et al. J Affect Disord. 2022;302:302-312
Fitzgerald PB et al. Brain Stimul. 2022;15(2):483-484
Malavera A et al. J Pain. 2016;17(8):911-8
Chang CH et al. Front Psychiatry. 2018;9:201
Nguyen JP et al. Neurophysiol Clin. 2017;47(1):47-53
Lee DJ et al. Ther Adv Psychopharmacol. 2017;8(2):73-92
Fitzsimmons SMDD, van der Werf YD, van Campen AD, et al. J Affect Disord. 2022;302:302-312
Tseng PT, Hsu CW, Hung CM, et al. Acta Psychiatr Scand. 2025;152(2):140-155
Li K, Qian L, Zhang C, et al. J Psychiatr Res. 2024;180:274-280
Bello D, Jones M, Gadiyar I, et al. JAMA Psychiatry. 2025;82(8):773-782
Pellegrini L, Garg K, Enara A, et al. Compr Psychiatry. 2022;118:152345
Kar SK, Agrawal A, Silva-Dos-Santos A, Gupta Y, Deng ZD. CNS Spectr. 2024;29(2):79-89
Liang K, Li H, Bu X, et al. Transl Psychiatry. 2021;11(1):332
Dehghani-Arani F, Kazemi R, Hallajian AH, et al. J Clin Med. 2024;13(18):5553
ECTECT efficiency for depression
▼
Sellevåg K, Bartz-Johannessen CA, Oedegaard KJ, et al. Biol Psychiatry Glob Open Sci. 2026;6(4):100722
Rovers JJE, van Zeijl NT, Tendolkar I, Dols A, van Eijndhoven PFP. BJPsych Open. 2026;12:e37
Heijnen WT et al. J Clin Psychopharmacol. 2010;30(5):616-9
Jelovac A et al. Neuropsychopharmacology. 2013;38(12):2467-74
Elias A et al. J Affect Disord. 2013;156:228-31
Spaans HP et al. Br J Psychiatry. 2014;206(1):67-71
Geduldig ET, Kellner CH. Curr Psychiatry Rep. 2016;18(4):40
Giacobbe P et al. J ECT. 2018;34(2):87-94
Espinoza RT, Kellner CH. N Engl J Med. 2022;386(7):667-672
Anand A, Mathew SJ, Sanacora G, et al. N Engl J Med. 2023;388(25):2315-2325
Menon V, Varadharajan N, Faheem A, Andrade C. JAMA Psychiatry. 2023;80(6):639-642
Berger SR, Kung S, Lapid MI. J ECT. 2025;41(1):39-44
Socci C, Medda P, Toni C, et al. J Affect Disord. 2018;227:627-631
ECTECT for bipolar disorder
▼
Schoeyen HK et al. Am J Psychiatry. 2014;172(1):41-51
Schoeyen HK et al. Am J Psychiatry. 2014;172(1):41-51
Minnai GP et al. J Affect Disord. 2016;195:180-4
Bahji A, Hawken ER, Sepehry AA, Cabrera CA, Vazquez G. Acta Psychiatr Scand. 2019;139(3):214-226
Zhang J, Wang G, Yang X, Gao K. Psychiatry Res. 2021;302:114027
Popiolek K, Bejerot S, Landén M, Nordenskjöld A. JAMA Netw Open. 2022;5(6):e2218406
Elias A, Thomas N, Sackeim HA. Am J Psychiatry. 2021;178(3):229-239
ECTECT for schizophrenia
▼
Grover S et al. Acta Neuropsychiatr. 2018;31(3):115-127
Ali SA et al. Mol Neuropsychiatry. 2019;5(2):75-83
Pawelczyk T et al. Neuropsychobiology. 2014;70(3):158-64
Rotharmel M et al. Asian J Psychiatr. 2019;44:6-7
Pawelczyk T et al. Neuropsychobiology. 2014;70(3):158-64
Sinclair DJ, Zhao S, Qi F, et al. Cochrane Database Syst Rev. 2019;3(3):CD011847
Pantoji M, Balachander S, Prajapati P, et al. Schizophr Res. 2025;278:69-79
Zheng W, Cao XL, Ungvari GS, et al. PLoS One. 2016;11(6):e0156510
Barros FMR, Tolentino A, Smaniotto L, et al. J ECT. 2026;42(1):3-11
Melzer-Ribeiro DL, Napolitano IC, Leite SA, et al. Schizophr Res. 2024;264:394-401
Kaster TS, Daskalakis ZJ, Blumberger DM. J Clin Psychiatry. 2017;78(4):e383-e389
Wang Z, Qiu J, Zhang P, Chen M, Wang X. Front Psychiatry. 2025;16:1523456
ECTECT: security, mechanisms and side effects
▼
Anderson D et al. J ECT. 2014;30(3):248-50
Sartorius A et al. Eur Neuropsychopharmacol. 2015;26(3):506-17
Semkovska M, McLoughlin DM. Biol Psychiatry. 2010;68(6):568-77
Kirov GG et al. Br J Psychiatry. 2015;208(3):266-70
Watts BV et al. J ECT. 2011;27(2):105-8
Baldinger P et al. J ECT. 2014;30(2):116-21
Rotheneichner P et al. Neural Plast. 2014;2014:723915
Bouckaert F et al. J Psychiatry Neurosci. 2016;41(2):105-14
Ota M et al. J Affect Disord. 2015;186:186-91
Leaver AM et al. Biol Psychiatry. 2018;85(6):466-476
Thomann PA et al. Brain Stimul. 2017;10(3):637-644
Miller ML et al. J ECT. 2019;35(1):27-34
Osler M et al. Lancet Psychiatry. 2018;5(4):348-356
Sauvaget A et al. Encephale. 2022;49(1):103-106
KETKetamine for depression
▼
Mathai DS, Cluck M, Aslam AM, et al. J Affect Disord. 2026 (online ahead of print)
Nikolin S, Rodgers A, Schwaab A, et al. EClinicalMedicine. 2023;62:102127
Moore TM et al. J Affect Disord. 2025;381:233-241
Lijffijt M et al. Neuropsychopharmacology. 2021;47(5):1088-1095
Singh JB et al. Am J Psychiatry. 2016;173(8):816-26
Feifel D et al. J Affect Disord. 2017;221:283-288
Forum Médical Suisse
BJPsych Open
Schwartz J et al. Evid Based Ment Health. 2016;19(2):35-8
Zanos P et al. Nature. 2016;533(7604):481-6
Pennybaker SJ et al. J Affect Disord. 2016;208:560-566
Kraus C et al. Int J Psychiatry Clin Pract. 2017;21(1):2-12
Albott CS et al. J Clin Psychiatry. 2018;79(3)
Thomas RK et al. J Psychopharmacol. 2018;32(10):1110-1117
Nikayin S et al. JAMA Psychiatry. 2022;79(7):736-738
Bahji A et al. J Affect Disord. 2020;278:542-555
KETKetamine for other indications
▼
Banov MD et al. CNS Spectr. 2019;25(3):331-342
Rodriguez CI et al. Neuropsychopharmacology. 2013;38(12):2475-83
Rodriguez CI et al. J Clin Psychiatry. 2011;72(4):567-9
Glue P et al. J Psychopharmacol. 2017;31(10):1302-1305
Feder A et al. JAMA Psychiatry. 2014;71(6):681-8
Feder A, Costi S, Rutter SB, et al. Am J Psychiatry. 2021;178(2):193-202
Yin L, Lu A, Le GH, et al. Acta Psychiatr Scand. 2026;153(2):140-153
Beaglehole B, Glue P, Neehoff S, et al. J Psychopharmacol. 2025;39(1):23-28
Kwan ATH, Lakhani M, Singh G, et al. CNS Spectr. 2024;29(6):531-541
Taylor JH, Landeros-Weisenberger A, Coughlin C, et al. Neuropsychopharmacology. 2018;43(2):325-333
Glue P, Neehoff S, Sabadel A, et al. J Psychopharmacol. 2020;34(3):267-272
Masdrakis VG, Tebbs Z, Natsis V, Baldwin DS. J Psychopharmacol. 2025;39(5):415-430
KETKetamine without psychotherapy: Evidence for standalone efficacy
▼
Veraart JKE, Schimmers N, Breeksema JJ et al. Clin Psychol Rev. 2026;124:102706
Simpson RJ, Juruena MF. Psychopharmacology (Berl). 2026
Moore TM, Walker K, Tung E et al. J Affect Disord. 2025;381:233-241
Joneborg I, Lee Y, Di Vincenzo JD et al. J Affect Disord. 2022;315:105-112
Wilkinson ST, Rhee TG, Joormann J et al. Psychother Psychosom. 2021;90(5):318-327
A/VAudio & Video
▼
Swissinfo
MISCOther useful resources
▼
Want to learn more?
Contact us to discuss treatment options suited to your situation.
